Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Labopin

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemiaO Ringdén, M Labopin, A Bacigalupo, et al.
Bone Marrow Transplantation|September 1, 1999
Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)O Ringdén, M Labopin, F Frassoni, et al.
Bone Marrow Transplantation|February 19, 2014
Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndromeA Nagler, M Labopin, R Berger, et al.
Bone Marrow Transplantation|April 11, 2017
More chronic GvHD and non-relapse mortality after peripheral blood stem cell compared with bone marrow in hematopoietic transplantation for paediatric acute lymphoblastic leukemia: a retrospective study on behalf of the EBMT Paediatric Diseases Working PartyM Simonin, A Dalissier, M Labopin, et al.
Leukemia|March 1, 1997
Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT)J Y Cahn, M Labopin, A Schattenberg, et al.
Bone Marrow Transplantation|November 1, 1996
Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationO Ringdén, M Labopin, E Gluckman, et al.
Bone Marrow Transplantation|August 18, 2015
Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantationG Battipaglia, A Ruggeri, E Brissot, et al.
Transplantation Proceedings|February 1, 1997
Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine. The Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)O Ringdén, M Labopin, E Gluckman, et al.
Bone Marrow Transplantation|June 2, 2015
Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantationL von Bahr, O Blennow, J Alm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow TransplantationA Bosi, D Laszlo, M Labopin, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemiaO Ringdén, M Labopin, A Bacigalupo, et al.
Bone Marrow Transplantation|September 1, 1999
Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)O Ringdén, M Labopin, F Frassoni, et al.
Bone Marrow Transplantation|February 19, 2014
Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndromeA Nagler, M Labopin, R Berger, et al.
Bone Marrow Transplantation|April 11, 2017
More chronic GvHD and non-relapse mortality after peripheral blood stem cell compared with bone marrow in hematopoietic transplantation for paediatric acute lymphoblastic leukemia: a retrospective study on behalf of the EBMT Paediatric Diseases Working PartyM Simonin, A Dalissier, M Labopin, et al.
Leukemia|March 1, 1997
Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT)J Y Cahn, M Labopin, A Schattenberg, et al.
Bone Marrow Transplantation|November 1, 1996
Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationO Ringdén, M Labopin, E Gluckman, et al.
Bone Marrow Transplantation|August 18, 2015
Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantationG Battipaglia, A Ruggeri, E Brissot, et al.
Transplantation Proceedings|February 1, 1997
Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine. The Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)O Ringdén, M Labopin, E Gluckman, et al.
Bone Marrow Transplantation|June 2, 2015
Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantationL von Bahr, O Blennow, J Alm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow TransplantationA Bosi, D Laszlo, M Labopin, et al.
Pageof 13